REDWOOD CITY, Calif., December 26, 2025--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...

RYVYL (RVYL) announced that its board of directors has approved a 1-for-35 reverse stock split of its common stock. The primary objective of the reverse split is to increase the per-share trading ...

New Haven-based Rallybio Corp. is asking shareholders to approve a reverse stock split as the clinical-stage biotechnology company works to regain compliance with Nasdaq’s minimum share-price rules ...

(RTTNews) - Adicet Bio (ACET) said its board has approved a one-for-16 reverse stock split of the company's common stock as part of efforts to regain compliance with Nasdaq's minimum bid price ...

Co-Diagnostics (CODX) announced that it has filed a Certificate of Amendment to its Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio of 1-for-30 shares. The ...

(RTTNews) - Aptevo Therapeutics Inc. (APVO), a clinical-stage biotechnology company, is scheduled to implement a 1-for-18 reverse stock split of its outstanding shares of common stock on December 29, ...

SALT LAKE CITY, Dec. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...

The reverse split will take effect at 12:01 a.m. Eastern Time on December 30, 2025, with the stock beginning to trade on a split-adjusted basis when markets open that day. The move will reduce ...

The MarketWatch News Department was not involved in the creation of this content. SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage ...

When I first looked at Microsoft Loop, I admittedly wrote it off and thought it wasn’t going to be worth my time. Then I started using it as one of my primary note-takers, and it completely changed my ...

Opendoor Technologies Inc. has pushed back a planned shareholder vote on a reverse stock split after a sharp rise in its share price. The move affects investors who were expecting a decision this week ...